Semin Thromb Hemost 2000; Volume 26(Number 03): 263-280
DOI: 10.1055/s-2000-8471
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Biological and Environmental Determinants of Plasma Homocysteine

JØRN. SCHNEEDE, HELGA. REFSUM, PER. MAGNE. UELAND
  • Department of Pharmacology, University of Bergen, Norway
Further Information

Publication History

Publication Date:
31 December 2000 (online)

ABSTRACT

This article gives an overview over common physiological, lifestyle, and pathological conditions that may modulate the homocysteine status. The interplay of several environmental factors, including age, gender, nutrition, smoking, and coffee consumption and physical activity with commonly used drugs and prevalent diseases are described. In most cases, an abnormal homocysteine status is not caused by a single factor alone but often is the result of combined effects. We address these frequently found ``clusters'' of homocysteine-modulating factors. Finally, we give an overview of likely causes of hyperhomocysteinemia found in an authentic material. This material is based on 2462 routine measurements of plasma total homocysteine carried out at the Haukeland University Hospital. The data represent the total number of combined homocysteine and methylmalonic acid determinations, requested by general practitioners in Norway during February 1998.

REFERENCES

  • 1 Refsum H, Ueland P M, Nygård O, Vollset S E. Homocysteine and cardiovascular disease.  Annu Rev Med . 1998;  49 31-62
  • 2 Tonstad S, Refsum H, Sivertsen M. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives.  Pediatr Res . 1996;  40 47-52
  • 3 Nygård O, Vollset S E, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.  JAMA . 1995;  274 1526-1533
  • 4 Tonstad S, Refsum H, Ueland P M. Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.  Circulation . 1997;  96 1803-1808
  • 5 Bjorke-Monsen A L, Vollset S E, Ueland P M, Refsum H. Plasma total homocysteine, vitamin status and the 5,10-methylenetetrahydrofolate reductase polymorphism in children.  Neth J Med . 1998;  51 S50
  • 6 Andersson A, Brattström L, Israelsson B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status.  Eur J Clin Invest . 1992;  22 79-87
  • 7 Anker G, Lonning P E, Ueland P M, Refsum H, Lien E A. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen.  Int J Cancer . 1995;  60 365-368
  • 8 Wouters M G, Moorrees M T, van der Mooren M J. Plasma homocysteine and menopausal status.  Eur J Clin Invest . 1995;  25 801-805
  • 9 Zmuda J M, Bausserman L L, Maceroni D, Thompson P D. The effect of supraphysiologic doses of testosterone on fasting total homocysteine levels in normal men.  Atherosclerosis . 1997;  130 199-202
  • 10 van der Mooren M J, Mijatovic V, van Baal W M, Stehouwer C D. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.  Maturitas . 1998;  30 27-36
  • 11 Mudd S H, Levy H L, Skovby F. Disorders of transsulfuration. in: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease New York: McGraw-Hill, 1995: 1279-1327
  • 12 Norlund L, Grubb A, Fex G. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.  Clin Chem Lab Med . 1998;  36 175-178
  • 13 Andersson A, Brattstrom L, Israelsson B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status.  Eur J Clin Invest . 1992;  22 79-87
  • 14 Kang S S, Wong P W, Zhou J M, Cook H Y. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women.  Metabolism . 1986;  35 889-891
  • 15 Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy.  Eur J Clin Chem Clin Biochem . 1992;  30 377-379
  • 16 Walker M C, Smith G N, Perkins S L, Keely E J, Garner P R. Changes in homocysteine levels during normal pregnancy.  Am J Obstet Gynecol . 1999;  180 660-664
  • 17 Bonnette R E, Caudill M A, Boddie A M. Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake.  Obstet Gynecol . 1998;  92 167-170
  • 18 Andersson A, Hultberg B, Brattström L, Isaksson A. Decreased serum homocysteine in pregnancy.  Eur J Clin Chem Clin Biochem . 1992;  30 377-379
  • 19 Malinow M R, Rajkovic A, Duell P B, Hess D L, Upson B M. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism.  Am J Obstet Gynecol . 1998;  178 228-233
  • 20 Hermann W, Quast S, Ullrich M. Hyperhomocysteinemia in high-aged subjects: Relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation.  Atherosclerosis . 1999;  144 91-101
  • 21 Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration.  Scand J Clin Lab Invest . 1996;  56 41-46
  • 22 Tucker K L, Selhub J, Wilson P W, Rosenberg I H. Dietary pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study.  J Nutr . 1996;  126 3025-3031
  • 23 Koehler K M, Pareo-Tubbeh S L, Romero L J, Baumgartner R N, Garry P J. Folate nutrition and older adults: Challenges and opportunities.  J Am Diet Assoc . 1997;  97 167-173
  • 24 Pennypacker L C, Allen R H, Kelly J P. High prevalence of cobalamin deficiency in elderly outpatients.  J Am Geriatr Soc . 1992;  40 1197-1204
  • 25 Lindenbaum J, Rosenberg I H, Wilson P W, Stabler S P, Allen R H. Prevalence of cobalamin deficiency in the Framingham elderly population.  Am J Clin Nutr . 1994;  60 2-11
  • 26 Allen R H, Lindenbaum J, Stabler S P. High prevalence of cobalamin deficiency in the elderly.  Trans Am Clin Climatol Assoc . 1995;  107 37-45
  • 27 Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.  Drugs Aging . 1998;  12 277-292
  • 28 van Asselt D Z, de Groot L C, van Staveren W A. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects.  Am J Clin Nutr . 1998;  68 328-334
  • 29 Saltzman J R, Russell R M. The aging gut. Nutritional issues.  Gastroenterol Clin North Am . 1998;  27 309-324
  • 30 Ubbink J B. Should all elderly people receive folate supplements?.  Drugs Aging . 1998;  13 415-420
  • 31 Wilcken D E, Wilcken B. B vitamins and homocysteine in cardiovascular disease and aging.  Ann NY Acad Sci . 1998;  854 361-370
  • 32 Carmel R. Cobalamin, the stomach, and aging.  Am J Clin Nutr . 1997;  66 750-759
  • 33 Mudd S H, Skovby F, Levy H L. The natural history of homocystinuria due to cystathionine beta-synthase deficiency.  Am J Hum Genet . 1985;  37 1-31
  • 34 Brenton D P, Cusworth D C, Dent C E, Jones E E. Homocystinuria. Clinical and dietary studies.  QJM . 1966;  35 325-346
  • 35 Tsai M Y, Garg U, Key N S. Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria.  Atherosclerosis . 1996;  122 69-77
  • 36 Ubbink J B, van der Merwe A, Delport R. The effect of a subnormal vitamin B-6 status on homocysteine metabolism.  J Clin Invest . 1996;  98 177-184
  • 37 Boers G H, Smals A G, Trijbels F J. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.  N Engl J Med . 1985;  313 709-715
  • 38 Engbersen A M, Franken D G, Boers G H. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.  Am J Hum Genet . 1995;  56 142-150
  • 39 Franken D G, Boers G HJ, Blom H J, Trijbels F JM, Kloppenborg P WC. Treatment of mild hyperhomocysteinemia in vascular disease patients.  Arterioscler Thromb . 1994;  14 465-470
  • 40 Ueland P M, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. in: Francis RBI, ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function New York: Marcel Dekker, 1992: 183-236
  • 41 Kang S S, Zhou J, Wong P W, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase.  Am J Hum Genet . 1988;  43 414-421
  • 42 Guttormsen A B, Ueland P M, Nesthus I. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.  J Clin Invest . 1996;  98 2174-2183
  • 43 Matthews R G, Sheppard C, Goulding C. Methylenetetrahydrofolate reductase and methionine synthase: Biochemistry and molecular biology.  Eur J Pediatr . 1998;  S54-S59 (S54-S59)
  • 44 Finkelstein J D, Martin J J. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.  J Biol Chem . 1984;  259 9508-9513
  • 45 Mansoor M A, Guttormsen A B, Fiskerstrand T. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration.  Clin Chem . 1993;  39 980-985
  • 46 Ueland P M, Mansoor M A, Guttormsen A B. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status-a possible element of the extracellular antioxidant defense system.  J Nutr . 1996;  126 1281S-1284S
  • 47 Guttormsen A B, Schneede J, Fiskerstrand T, Ueland P M, Refsum H M. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.  J Nutr . 1994;  124 1934-1941
  • 48 Andersson A, Brattström L, Israelsson B, Isaksson A, Hultberg B. The effect of excess daily methionine intake on plasma homocysteine after a methionine loading test in humans.  Clin Chim Acta . 1990;  192 69-76
  • 49 den Heijer M, Bos G MJ, Brouwer I A, Gerrits W BJ, Blom H J. Variability of the methionine loading test: No effect of a low protein diet.  Ann Clin Biochem . 1996;  33 551-554
  • 50 Shimakawa T, Nieto F J, Malinow M R. Vitamin intake: A possible determinant of plasma homocyst(e)ine among middle-aged adults.  Ann Epidemiol . 1997;  7 285-293
  • 51 Stolzenberg-Solomon R Z, Miller E R, Maguire M G, Selhub J, Appel L J. Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population.  Am J Clin Nutr . 1999;  69 467-475
  • 52 Verhoef P, Stampfer M J, Buring J E. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate.  Am J Epidemiol . 1996;  143 845-859
  • 53 Mann N J, Dudman N, Guo X W, Li D, Sinclair A J. The effect of diet on homocysteine levels in healthy male subjects.  Neth J Med . 1998;  52 S10
  • 54 Nygård O, Refsum H, Ueland P M, Vollset S E. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study.  Am J Clin Nutr . 1998;  67 263-270
  • 55 Wei M M, Gregory J F. Organic acids in selected foods inhibit intestinal brush border pteroylpolyglutamate hydrolase in vitro: Potential mechanisms affecting the bioavailability of dietary polyglutamyl folate.  J Agr Food Chem . 1998;  46 211-219
  • 56 Omenn G S, Beresford S A, Motulsky A G. Preventing coronary heart disease: B vitamins and homocysteine.  Circulation . 1998;  97 421-424
  • 57 Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.  BMJ . 1998;  316 894-898
  • 58 Jacob R A, Wu M M, Henning S M, Swendseid M E. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction.  J Nutr . 1994;  124 1072-1080
  • 59 O'Keefe C A, Bailey L B, Thomas E A. Controlled dietary folate affects folate status in nonpregnant women.  J Nutr . 1995;  125 2717-2725
  • 60 Malinow M R, Duell P B, Hess D L. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.  N Engl J Med . 1998;  338 1009-1015
  • 61 Ubbink J B, Becker P J, Vermaak W J, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine.  Clin Chem . 1995;  41 1033-1037
  • 62 Rasmussen K, Moller J, Lyngbak M, Pedersen A M, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation.  Clin Chem . 1996;  42 630-663
  • 63 Joosten E, Lesaffre E, Riezler R. Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people?.  Eur J Haematol . 1996;  57 222-226
  • 64 Gregory J F. Chemical and nutritional aspects of folate research-analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates.  Adv Food Nutr Res . 1990;  33 1-101
  • 65 Seyoum E, Selhub J. Properties of food folates determined by stability and susceptibility to intestinal pteroylpolyglutamate hydrolase action.  J Nutr . 1998;  128 1956-1960
  • 66 Rogers L M, Pfeiffer C M, Bailey L B, Gregory J F. A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability in humans: Evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2] folic acid.  J Nutr . 1997;  127 2321-2327
  • 67 Bailey L B. Evaluation of a new Recommended Dietary Allowance for folate.  J Am Diet Assoc . 1992;  92 463-478
  • 68 Gimsing P, Melgaard B, Andersen K, Vilstrup H, Hippe E. Vitamin B-12 and folate function in chronic alcoholic men with peripheral neuropathy and encephalopathy.  J Nutr . 1989;  119 416-424
  • 69 Piyathilake C J, Hine R J, Dasanayake A P. Effect of smoking on folate levels in buccal mucosal cells.  Int J Cancer . 1992;  52 566-569
  • 70 Halsted C H, Villaneuva J, Chandler C J. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation.  Hepatology . 1996;  23 497-505
  • 71 Gloria L, Cravo M, Camilo M E. Nutritional deficiencies in chronic alcoholics: Relation to dietary intake and alcohol consumption.  Am J Gastroenterol . 1997;  92 485-489
  • 72 Aubin H J, Laureaux C, Zerah F. Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics.  Biol Psychiatry . 1998;  44 638-643
  • 73 Chen J, Giovannucci E L, Hunter D J. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S  men and women: An example of gene-environment interactions in colorectal tumorigenesis. J Nutr . 1999;  129 560S-564S
  • 74 Wu L L, Wu J, Hunt S C. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.  Clin Chem . 1994;  40 552-561
  • 75 Bergmark C, Mansoor M A, Swedenborg J. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50-effect of smoking and extent of disease.  Eur J Vasc Surg . 1993;  7 391-396
  • 76 Mansoor M A, Bergmark C, Svardal A M, Lonning P E, Ueland P M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.  Arterioscler Thromb Vasc Biol . 1995;  15 232-240
  • 77 Fernandez-Banares F, Gine J J, Cabre E. Factors associated with low values of biochemical vitamin parameters in healthy subjects.  Int J Vitam Nutr Res . 1994;  64 68-74
  • 78 Ortega R M, Lopez-Sobaler A M, Gonzalez-Gross M M. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men.  J Am Coll Nutr . 1994;  13 68-72
  • 79 Mansoor M A, Kristensen O, Hervig T. Low concentrations of folate in serum and erythrocytes of smokers: Methionine loading decreases folate concentrations in serum of smokers and nonsmokers.  Clin Chem . 1997;  43 2192-2194
  • 80 Wright A J, Finglas P M, Southon S. Erythrocyte folate analysis: A cause for concern?.  Clin Chem . 1998;  44 1886-1891
  • 81 Berger J, Wynder E L. The correlation of epidemiological variables.  J Clin Epidemiol . 1994;  47 941-952
  • 82 Preston A M. Cigarette smoking-nutritional implications.  Prog Food Nutr Sci . 1991;  15 183-217
  • 83 Zondervan K T, Ocke M C, Smit H A, Seidell J C. Do dietary and supplementary intakes of antioxidants differ with smoking status?.  Int J Epidemiol . 1996;  25 70-79
  • 84 Piyathilake C J, Macaluso M, Hine R J, Richards E W, Krumdieck C L. Local and systemic effects of cigarette smoking on folate and vitamin B-12.  Am J Clin Nutr . 1994;  60 559-566
  • 85 Vermaak W JH, Ubbink J B, Barnard H C. Vitamin B-6 nutrition status and cigarette smoking.  Am J Clin Nutr . 1990;  51 1058-1061
  • 86 Giraud D W, Martin H D, Driskell J A. Erythrocyte and plasma B-6 vitamin concentrations of long-term tobacco smokers, chewers, and nonusers.  Am J Clin Nutr . 1995;  62 104-109
  • 87 Eiserich J P, Vandervliet A, Handelman G J, Halliwell B, Cross C E. Dietary antioxidants and cigarette smoke-induced biomolecular damage: A complex interaction.  Am J Clin Nutr . 1995;  62 S1490-S1500
  • 88 Ueland P M. Homocysteine species as components of plasma redox thiol status.  Clin Chem . 1995;  41 340-342
  • 89 Nygård O, Refsum H, Ueland P M. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study.  Am J Clin Nutr . 1997;  65 136-143
  • 90 Folsom A R, Nieto F J, McGovern P G. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study.  Circulation . 1998;  98 204-210
  • 91 Jacobsen B K, Thelle D S. The Tromsø Heart Study: Is coffee drinking an indicator of life style with high risk for ischemic heart disease?.  Acta Med Scand . 1987;  222 215-221
  • 92 Schwarz B, Bischof H P, Kunze M. Coffee, tea, and lifestyle.  Prev Med . 1994;  23 377-384
  • 93 Holycross B J, Jackson E K. Effects of chronic treatment with caffeine on kidney responses to angiotensin II.  Eur J Pharmacol . 1992;  219 361-367
  • 94 Vollset S E, Nygård O, Kvåle G, Ueland P M, Refsum H. Lifestyle and total plasma homocysteine in Western Norway. in: Graham I, Refsum H, Rosenberg IH, Ueland PM, eds. Homocysteine Metabolism. From Basic Science to Clinical Medicine Boston: Kluwer Academic Publisher, 1997: 177-182
  • 96 Hultberg B, Andersson A, Masson P, Larson M, Tunek A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine.  Scand J Clin Lab Invest . 1995;  54 417-422
  • 97 Kenyon S H, Nicolaou A, Gibbons W A. The effect of ethanol and its metabolites upon methionine synthase activity in vitro.  Alcohol . 1998;  15 305-309
  • 98 Cravo M L, Gloria L M, Selhub J. Hyperhomocysteinemia in chronic alcoholism: Correlation with folate, vitamin B-12, and vitamin B-6 status.  Am J Clin Nutr . 1996;  63 220-224
  • 99 Lindenbaum J. Malabsorption of vitamin B12 and folate.  Curr Concepts Nutr . 1980;  9 105-123
  • 100 Blocker D E, Thenen S W. Intestinal absorption, liver update, and excretion of 3H-folic acid in folic acid-deficient, alcohol-consuming nonhuman primates.  Am J Clin Nutr . 1987;  46 503-510
  • 101 Halsted C H. Jejunal brush-border folate hydrolase. A novel enzyme.  West J Med . 1991;  155 605-609
  • 102 Lussier-Cacan S, Xhignesse M, Piolot A. Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits.  Am J Clin Nutr . 1996;  64 587-593
  • 103 Malinow M R, Levenson J, Giral P. Role of blood pressure, uric acid, and hemorrheological parameters on plasma homocyst(e)ine concentration.  Atherosclerosis . 1995;  114 175-183
  • 104 Brolin R E, Gorman R C, Milgrim L M, Kenler H A. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies.  Int J Obes . 1991;  15 661-667
  • 105 Gurewitsch E D, Smith-Levitin M, Mack J. Pregnancy following gastric bypass surgery for morbid obesity.  Obstet Gynecol . 1996;  88 658-661
  • 106 Provenzale D, Reinhold R B, Golner B. Evidence for diminished B12 absorption after gastric bypass: Oral supplementation does not prevent low plasma B12 levels in bypass patients.  J Am Coll Nutr . 1992;  11 29-35
  • 107 Rhode B M, Arseneau P, Cooper B A. Vitamin B12 deficiency after gastric surgery for obesity.  Am J Clin Nutr . 1996;  63 103-109
  • 108 Allen R H, Stabler S P, Savage D G, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.  FASEB J . 1993;  7 1344-1353
  • 109 Ubbink J B. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.  J Inherit Metab Dis . 1997;  20 316-325
  • 110 Lewis R. Anemia-a common but never a normal concomitant of aging.  Geriatrics . 1976;  31 53-60
  • 111 Lindenbaum J. Aspects of vitamin B12 and folate metabolism in malabsorption syndromes.  Am J Med . 1979;  67 1037-1048
  • 112 Russell R M. Changes in gastrointestinal function attributed to aging.  Am J Clin Nutr . 1992;  1203S-1207S (1203S-1207S)
  • 113 Matthews J H. Cobalamin and folate deficiency in the elderly.  Baillieres Clin Haematol . 1995;  8 679-697
  • 114 Chanarin I, Deacon R, Lumb M, Muir M, Perry J. Cobalamin-folate interrelations: A critical review.  Blood . 1985;  66 479-489
  • 115 Shane B, Stokstad E L. Vitamin B12-folate interrelationships.  Annu Rev Nutr . 1985;  5 115-141
  • 116 Miller J W, Nadeau M R, Smith D, Selhub J. Vitamin B-6 deficiency vs folate deficiency-comparison of responses to methionine loading in rats.  Am J Clin Nutr . 1994;  59 1033-1039
  • 117 Pietrzik K, Bronstrup A. Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population.  Eur J Pediatr . 1998;  S135-S138 (S135-S138)
  • 118 Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women.  Int J Vitam Nutr Res . 1998;  68 98-103
  • 119 Selhub J, Jacques P F, Wilson P W, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.  JAMA . 1993;  270 2693-2698
  • 120 Joosten E, van den Berg A, Riezler R. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people.  Am J Clin Nutr . 1993;  58 468-476
  • 121 Ellis J M, McCully K S. Prevention of myocardial infarction by vitamin B6 .  Res Commun Mol Pathol Pharmacol . 1995;  89 208-220
  • 122 Robinson K, Mayer E L, Miller D P. Hyperhomocysteinemia and low pyridoxal phosphate.  Common and independent reversible risk factors for coronary artery disease. Circulation . 1995;  92 2825-2830
  • 123 Chasan-Taber L, Selhub J, Rosenberg I H. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.  J Am Coll Nutr . 1996;  15 136-143
  • 124 Malinow M R, Nieto F J, Kruger W D. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.  Arterioscler Thromb Vasc Biol . 1997;  17 1157-1162
  • 125 Riley W J, Toskes P P, Maclaren N K, Silverstein J H. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes.  Diabetes . 1982;  31 1051-1055
  • 126 Stene-Larsen G, Mosvold J, Ly B. Selective vitamin B12 malabsorption in adult coeliac disease. Report on three cases with associated autoimmune diseases.  Scand J Gastroenterol . 1988;  23 1105-1108
  • 127 Ottesen M, Feldt-Rasmussen U, Andersen J, Hippe E, Schouboe A. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment.  J Endocrinol Invest . 1995;  18 91-97
  • 128 Gupta A, Robinson K. Hyperhomocysteinaemia and end stage renal disease.  J Nephrol . 1997;  10 77-84
  • 129 Hoogstraten B, Baker H, Gilbert H S. Serum folate and serum vitamin B12 in patients with malignant hematologic diseases.  Cancer Res . 1965;  25 1933-1938
  • 130 Hines J D, Halsted C H, Griggs R C, Harris J W. Megaloblastic anemia secondary to folate deficiency associated with hypothyroidism.  Ann Intern Med . 1968;  68 792-805
  • 131 Stokstad E L, Chan M M, Watson J E, Brody T. Nutritional interactions of vitamin B12, folic acid, and thyroxine.  Ann N Y Acad Sci . 1980;  355 119-129
  • 132 Levitt A J, Joffe R T. Folate, B12 and thyroid function in depression.  Biol Psychiatry . 1993;  33 52-53
  • 133 Ambrosi P, Barlatier A, Habib G. Hyperhomocysteinaemia in heart transplant recipients.  Eur Heart J . 1994;  15 1191-1195
  • 134 Berger P B, Jones J D, Olson L J. Increase in total plasma homocysteine concentration after cardiac transplantation.  Mayo Clin Proc . 1995;  70 125-131
  • 135 Ambrosi P, Garcon D, Riberi A. Association of mild hyperhomocysteinemia with cardiac graft vascular disease.  Atherosclerosis . 1998;  138 347-350
  • 136 Cole D E, Ross H J, Evrovski J. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients.  Clin Chem . 1998;  44 2307-2312
  • 137 Fodinger M, Wolfl G, Fischer G. Effect of MTHFR 677C > T on plasma total homocysteine levels in renal graft recipients.  Kidney Int . 1999;  55 1072-1080
  • 138 Gupta A, Moustapha A, Jacobsen D W. High homocysteine, low folate, and low vitamin B6 concentrations: Prevalent risk factors for vascular disease in heart transplant recipients.  Transplantation . 1998;  65 544-550
  • 139 Ueland P M, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy.  J Lab Clin Med . 1989;  114 473-501
  • 140 Refsum H, Ueland P M. Clinical significance of pharmacological modulation of homocysteine metabolism.  Trends Pharmacol Sci . 1990;  11 411-416
  • 141 Ueland P M, Fiskerstrand T, Lien E A, Refsum H. Homocysteine and drug therapy. in: Graham I, Refsum H, Rosenberg IH, Ueland PM, eds. Homocysteine Metabolism. From Basic Science to Clinical Medicine Boston: Kluwer Academic Publisher, 1997: 145-152
  • 142 Ueland P M, Refsum H, Schneede J. Determinants of plasma homocysteine. In:Robinson K, ed. Homocysteine and Vascular Disease. Dordrecht, The Netherlands: Kluwer Academic; 2000: 45-54
  • 143 Refsum H, Ueland P M, Kvinnsland S. Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine.  Cancer Res . 1986;  46 5385-5391
  • 144 Refsum H, Wesenberg F, Ueland P M. Plasma homocysteine in children with acute lymphoblastic leukemia: Changes during a chemotherapeutic regimen including methotrexate.  Cancer Res . 1991;  51 828-835
  • 145 Refsum H, Helland S, Ueland P M. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low-dose methotrexate treatment.  Clin Pharmacol Ther . 1989;  46 510-520
  • 146 Morgan S L, Baggott J E, Refsum H, Ueland P M. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate.  Clin Pharmacol Ther . 1991;  50 547-556
  • 147 Morgan S L, Baggott J E, Lee J Y, Alarcon G S. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention.  J Rheumatol . 1998;  25 441-446
  • 148 van Ede A E, Laan R F, Blom H J, De Abreau R A, van de Putte L B. Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity.  Semin Arthritis Rheum . 1998;  27 277-292
  • 149 James G K, Jones M W, Pudek M R. Homocyst(e)ine levels in patients on phenytoin therapy.  Clin Biochem . 1997;  30 647-649
  • 150 Ono H, Sakamoto A, Eguchi T. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.  Metabolism . 1997;  46 959-962
  • 151 Carl G F, Smith M L, Furman G M. Phenytoin treatment and folate supplementation affect folate concentrations and methylation capacity in rats.  J Nutr . 1991;  121 1214-1221
  • 152 Yoo J H, Hong S B. A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants.  Metabolism . 1999;  48 1047-1051
  • 153 Blankenhorn D H, Malinow M R, Mack W J. Colestipol plus niacin therapy elevates plasma homocyst(e)ine levels.  Coron Artery Disease . 1991;  2 357-360
  • 154 Tonstad S, Refsum H, Ose L, Ueland P M. The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine.  J Pediatr . 1998;  132 365-368
  • 155 Ermens A A, Schoester M, Spijkers L J, Lindemans J, Abels J. Toxicity of methotrexate in rats preexposed to nitrous oxide.  Cancer Res . 1989;  49 6337-6341
  • 156 Christensen B, Guttormsen A B, Schneede J. Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia.  Anesthesiology . 1994;  80 1046-1056
  • 157 Guttormsen A B, Refsum H, Ueland P M. The interaction between nitrous oxide and cobalamin.  Biochemical effects and clinical consequences. Acta Anaesthesiol Scand . 1994;  38 753-756
  • 158 Drummond J T, Matthews R G. Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: Characterization of the damage to the enzyme and prosthetic group.  Biochemistry . 1994;  33 3742-3750
  • 159 Drummond J T, Matthews R G. Nitrous oxide degradation by cobalamin-dependent methionine synthase: Characterization of the reactants and products in the inactivation reaction.  Biochemistry . 1994;  33 3732-3741
  • 160 Coronato A, Glass G B. Depression of the intestinal uptake of radio-vitamin B12 by cholestyramine.  Proc Soc Exp Biol Med . 1973;  142 1341-1344
  • 161 Force R W, Nahata M C. Effect of histamine H2-receptor antagonists on vitamin B12 absorption.  Ann Pharmacother . 1992;  26 1283-1286
  • 162 Saltzman J R, Kemp J A, Golner B B. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption.  J Am Coll Nutr . 1994;  13 584-591
  • 163 Bellou A, Aimone-Gastin I, De Korwin J D. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy.  J Intern Med . 1996;  240 161-164
  • 164 Schenk B E, Festen H P, Kuipers E J, Klinkenberg-Knol E C, Meuwissen S G. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin.  Aliment Pharmacol Ther . 1996;  10 541-545
  • 165 Termanini B, Gibril F, Sutliff V E. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.  Am J Med . 1998;  104 422-430
  • 166 Tomkin G H, Hadden D R, Weaver J A, Montgomery D A. Vitamin-B12 status of patients on long-term metformin therapy.  BMJ . 1971;  2 685-687
  • 167 Tomkin G H. Malabsorption of vitamin B12 in diabetic patients treated with phenformin: A comparison with metformin.  BMJ . 1973;  3 673-675
  • 168 Callaghan T S, Hadden D R, Tomkin G H. Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment.  BMJ . 1980;  280 1214-1215
  • 169 Adams J F, Clark J S, Ireland J T, Kesson C M, Watson W S. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy.  Diabetologia . 1983;  24 16-18
  • 170 Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.  J Pediatr . 1996;  129 42-49
  • 171 Carlsen S M, Folling I, Grill V. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.  Scand J Clin Lab Invest . 1997;  57 521-527
  • 172 Hoogeveen E K, Kostense P J, Jakobs C. Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?.  J Intern Med . 1997;  242 389-394
  • 173 Aarsand A K, Carlsen S M. Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.  J Intern Med . 1998;  244 169-174
  • 174 Shaw J T, McWhinney B, Tate J R. Plasma homocysteine levels in indigenous Australians.  Med J Aust . 1999;  170 19-22
  • 175 Laine-Cessac P, Cailleux A, Allain P. Mechanisms of the inhibition of human erythrocyte pyridoxal kinase by drugs.  Biochem Pharmacol . 1997;  54 863-870
  • 176 Drell W, Welch A D. Azaribine-homocystinemia-thrombosis in historical perspective.  Pharmacol Ther . 1989;  41 195-206
  • 177 Krishnaswamy K. Isonicotinic acid hydrazide and pyridoxine deficiency.  Int J Vitam Nutr Res . 1974;  44 457-465
  • 178 Basu T K, Mann S. Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects.  J Nutr . 1997;  127 117-121
  • 179 Brattström L, Israelsson B, Olsson A, Andersson A, Hultberg B. Plasma homocysteine in women in oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma.  Scand J Clin Lab Invest . 1992;  52 283-287
  • 180 van der Mooren M J, Demacker P N, Blom H J, de Rijke Y B, Rolland R. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.  Fertil Steril . 1997;  67 67-73
  • 181 Giri S, Thompson P D, Taxel P. Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.  Atherosclerosis . 1998;  137 359-366
  • 182 Giltay E J, Hoogeveen E K, Elbers J M. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females.  J Clin Endocrinol Metab . 1998;  83 550-553
  • 183 Steegers-Theunissen R P, Boers G H, Steegers E A. Effects of sub-50 oral contraceptives on homocysteine metabolism: A preliminary study.  Contraception . 1992;  45 129-139
  • 184 Shojania A M. Oral contraceptives: Effect of folate and vitamin B12 metabolism.  Can Med Assoc J . 1982;  126 244-247
  • 185 Miller L T. Do oral contraceptive agents affect nutrient requirements-vitamin B-6?.  J Nutr . 1986;  116 1344-1345
  • 186 Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.  Transplantation . 1996;  61 509-512
  • 187 Dennis V W, Robinson K. Homocysteinemia and vascular disease in end-stage renal disease.  Kidney Int Suppl . 1996;  57 S11-S17
  • 188 Robinson K, Gupta A, Dennis V. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.  Circulation . 1996;  94 2743-2748
  • 189 Bostom A G, Shemin D, Verhoef P. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.  Arterioscler Thromb Vasc Biol . 1997;  17 2554-2558
  • 190 van Guldener C, Janssen M J, Stehouwer C D. The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function.  Neth J Med . 1998;  52 58-64
  • 191 Bostom A, Brosnan J T, Hall B, Nadeau M R, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo.  Atherosclerosis . 1995;  116 59-62
  • 192 van<&&>Guldener C, Donker A J, Jakobs C. No net renal extraction of homocysteine in fasting humans.  Kidney Int . 1998;  54 166-169
  • 193 Bostom A G, Shemin D, Lapane K L. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.  Atherosclerosis . 1996;  123 193-202
  • 194 Bostom A G, Shemin D, Lapane K L. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.  Kidney Int . 1996;  49 147-152
  • 195 Dierkes J, Domrose U, Ambrosch A. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.  Clin Nephrol . 1999;  51 108-115
  • 196 House A A, Donnelly J G. Effect of multivitamins on plasma homocysteine and folate levels in patients on hemodialysis.  ASAIO J . 1999;  45 94-97
  • 197 Ramirez G, Chen M, Boyce<&&>Jr H W. Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation.  Kidney Int . 1986;  30 99-106
  • 198 Stein G, Sperschneider H, Koppe S. Vitamin levels in chronic renal failure and need for supplementation.  Blood Purif . 1985;  3 52-62
  • 199 Dierkes J, Domröse U, Ambrosch A. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.  Metabolism . 1999;  48 631-635
  • 200 Refsum H, Wesenberg F, Ueland P M. Plasma homocysteine in children with acute lymphoblastic leukemia. Changes during a chemotherapeutic regimen including methotrexate.  Cancer Res . 1991;  51 828-835
  • 201 Christensen B, Refsum H, Vintermyr O, Ueland P M. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: Methionine loading of non-transformed, transformed, proliferating and quiescent cells in culture.  J Cell Physiol . 1991;  146 52-62
  • 202 Bates C J, Pentieva K D, Prentice A, Mansoor M A, Finch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over.  Br J Nutr . 1999;  81 191-201
  • 203 Haagsma C J, Blom H J, van Riel P L. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.  Ann Rheum Dis . 1999;  58 79-84
  • 204 Hernanz A, Plaza A, Martin-Mola E, De Miguel E. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women.  Clin Biochem . 1999;  32 65-70
  • 205 Pettersson T, Friman C, Abrahamsson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia.  J Rheumatol . 1998;  25 859-863
  • 206 Petterson T, Friman C, Abrahamson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia.  J Rheumatol . 1998;  25 859-863
  • 207 Roubenoff R, Dellaripa P, Nadeau M R. Abnormal homocysteine metabolism in rheumatoid arthritis.  Arthritis Rheum . 1997;  40 718-722
  • 208 Krogh<&&>Jensen M, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.  Scand J Clin Lab Invest . 1996;  56 421-429
  • 209 Perrett D. The metabolism and pharmacology of D-penicillamine in man.  J Rheumatol Suppl . 1981;  7 41-50
  • 210 Kang S S, Wong P W, Glickman P B, MacLeod C M, Jaffe I A. Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatment.  J Clin Pharmacol . 1986;  26 712-725
  • 211 Cattaneo M, Vecchi M, Zighetti M L. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?.  Thromb Haemost . 1998;  80 542-545
  • 212 Mahmud N, Molloy A, McPartlin J. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.  Gut . 1999;  45 389-394
  • 213 Hultberg B, Agardh E, Andersson A. Increased levels of plasma homocysteine are associated with nephropathy but not severe retinopathy in type 1 diabetes mellitus.  Scand J Lab Clin Invest . 1991;  51 277-282
  • 214 Agardh C D, Agardh E, Andersson A, Hultberg B. Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus.  Scand J Lab Invest . 1987;  54 637-641
  • 215 Chico A, Perez A, Cordoba A. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease?.  Diabetologia . 1998;  41 684-693
  • 216 Hultberg B, Agardh C D, Agardh E, Lovestam-Adrian M. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study.  Scand J Clin Lab Invest . 1997;  57 595-600
  • 217 Caspary W F, Zavada I, Reimold W. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides.  Diabetologia . 1977;  13 187-193
  • 218 Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: Effect of parenteral methylcobalamin treatment.  Atherosclerosis . 1993;  103 149-157
  • 219 Hofmann M A, Kohl B, Zumbach M S. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.  Diabetes Care . 1998;  21 841-848
  • 220 Hoogeveen E K, Kostense P J, Beks P J. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study.  Arterioscler Thromb Vasc Biol . 1998;  18 133-138
  • 221 Munshi M N, Stone A, Fink L, Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.  Metabolism . 1996;  45 133-135
  • 222 Vaccaro O, Ingrosso D, Rivellese A, Greco G, Riccardi G. Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes.  Lancet . 1997;  349 1102-1103
  • 223 Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy.  Lancet . 1997;  349 473-474
  • 224 Lanfredini M, Fiorina P, Peca M G. Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.  Metabolism . 1998;  47 915-921
  • 225 Hoogeveen E K, Kostense P J, Jager A. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study.  Kidney Int . 1998;  54 203-209
  • 226 Robillon J F, Canivet B, Candito M. Type 1 diabetes mellitus and homocyst(e)ine.  Diabetes Metab . 1994;  20 494-496
  • 227 Wollesen F, Brattstrom L, Refsum H. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.  Kidney Int . 1999;  55 1028-1035
  • 228 Giltay E J, Hoogeveen E K, Elbers J M. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects.  Atherosclerosis . 1998;  139 197-198
  • 229 Fonseca V A, Mudaliar S, Schmidt B. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.  Metabolism . 1998;  47 686-689
  • 230 Nedrebo B G, Ericsson U B, Nygård O. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.  Metabolism . 1998;  47 89-93
  • 231 Cimino J A, Jhangiani S, Schwartz E, Cooperman J M. Riboflavin metabolism in the hypothyroid human adult.  Proc Soc Exp Biol Med . 1987;  184 151-153
  • 232 Nair C P, Viswanathan G, Noronha J M. Folate-mediated incorporation of ring-2-carbon of histidine into nucleic acids: Influence of thyroid hormone.  Metabolism . 1994;  43 1575-1578
  • 233 Montenegro J, Gonzalez O, Saracho R, Aguirre R, Martinez I. Changes in renal function in primary hypothyroidism.  Am J Kidney Dis . 1996;  27 195-198
  • 234 Capasso G, De<&&>Tommaso G, Pica A. Effects of thyroid hormones on heart and kidney functions.  Miner Electrolyte Metab . 1999;  25 56-64
  • 235 Kreisman S H, Hennessey J V. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism.  Arch Intern Med . 1999;  159 79-82
  • 236 Hussein W I, Green R, Jacobsen D W, Faiman C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism.  Ann Intern Med . 1999;  131 348-351
  • 237 Lien E A, Nedrebø B G, Varhaug J E. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism.  J Clin Endocrinol Metabol . 2000;  85 1049-1053
  • 238 Fernandez-Banares F, Abad-Lacruz A, Xiol X. Vitamin status in patients with inflammatory bowel disease.  Am J Gastroenterol . 1989;  84 744-748
  • 239 Gonera R K, Timmerhuis T P, Leyten A C, van der Heul C. Two thrombotic complications in a patient with active ulcerative colitis.  Neth J Med . 1997;  50 88-91
  • 240 Slot W B, van Kasteel V, Coerkamp E G, Seelen P J, van der Werf S D. Severe thrombotic complications in a postpartum patient with active Crohn's disease resulting in ischemic spinal cord injury.  Dig Dis Sci . 1995;  40 1395-1399
  • 241 Lambert D, Benhayoun S, Adjalla C. Crohn's disease and vitamin B12 metabolism.  Dig Dis Sci . 1996;  41 1417-1422
  • 242 Penix L P. Ischemic strokes secondary to vitamin B12 deficiency-induced hyperhomocystinemia.  Neurology . 1998;  51 622-624
  • 243 Hoffbrand A V, Douglas A P, Fry L, Stewart J S. Malabsorption of dietary folate (Pteroylpolyglutamates) in adult coeliac disease and dermatitis herpetiformis.  BMJ . 1970;  4 85-89
  • 244 Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel diseases.  Scand J Gastroenterol . 1979;  14 1019-1024
  • 245 Bechi P, Briganti S, Borsotti M. Folate deficiency in operated terminal ileitis (Crohn's disease).  Ital J Surg Sci . 1983;  13 13-19
  • 246 Imes S, Pinchbeck B R, Dinwoodie A, Walker K, Thomson A B. Iron, folate, vitamin B-12, zinc, and copper status in outpatients with Crohn's disease: Effect of diet counseling.  J Am Diet Assoc . 1987;  87 928-930
  • 247 Steger G G, Mader R M, Vogelsang H. Folate absorption in Crohn's disease.  Digestion . 1994;  55 234-238
  • 248 Pittschieler K. Neutropenia, granulocytic hypersegmentation and coeliac disease.  Acta Paediatr . 1995;  84 705-706
  • 249 Burke A, Lichtenstein G R, Rombeau J L. Nutrition and ulcerative colitis.  Baillieres Clin Gastroenterol . 1997;  11 153-174
  • 250 Kennedy H J, Callender S T, Truelove S C, Warner G T. Haematological aspects of life with an ileostomy.  Br J Haematol . 1982;  52 445-454
  • 251 Fiorentini M T, Locatelli L, Ceccopieri B. Physiology of ileoanal anastomosis with ileal reservoir for ulcerative colitis and adenomatosis coli.  Dis Colon Rectum . 1987;  30 267-272
  • 252 Neale G, Gompertz D, Schonsby H, Tabaqchali S, Booth C C. The metabolic and nutritional consequences of bacterial overgrowth in the small intestine.  Am J Clin Nutr . 1972;  25 1409-1417
  • 253 Gracey M. Mechanisms of malabsorption in the ``contaminated small-bowel syndrome''.  Nahrung . 1984;  28 659-666
  • 254 Franklin J L, Rosenberg H H. Impaired folic acid absorption in inflammatory bowel disease: Effects of salicylazosulfapyridine (Azulfidine).  Gastroenterology . 1973;  64 517-525
  • 255 Baum C L, Selhub J, Rosenberg I H. Antifolate actions of sulfasalazine on intact lymphocytes.  J Lab Clin Med . 1981;  97 779-784
  • 256 Swinson C M, Perry J, Lumb M, Levi A J. Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis.  Gut . 1981;  22 456-461
  • 257 Pironi L, Cornia G L, Ursitti M A. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine.  Int J Clin Pharmacol Res . 1988;  8 143-148
  • 258 Lucas M L, Cooper B T, Lei F H. Acid microclimate in coeliac and Crohn's disease: A model for folate malabsorption.  Gut . 1978;  19 735-742
  • 259 Lucas M L, Mathan V I. Jejunal surface pH measurements in tropical sprue.  Trans R Soc Trop Med Hyg . 1989;  83 138-142
  • 260 Harju E. Metabolic problems after gastric surgery.  Int Surg . 1990;  75 27-35
  • 261 Avinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery.  Surgery . 1992;  111 137-142
  • 262 Grange D K, Finlay J L. Nutritional vitamin B12 deficiency in a breastfed infant following maternal gastric bypass.  Pediatr Hematol Oncol . 1994;  11 311-318
  • 263 Sumner A E, Chin M M, Abrahm J L. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery.  Ann Intern Med . 1996;  124 469-476
  • 264 Borson-Chazot F, Harthe C, Teboul F. Occurrence of hyperhomocysteinemia 1 year after gastroplasty for severe obesity.  J Clin Endocrinol Metab . 1999;  84 541-545
  • 265 Loeschke K, Bolkert T, Kiefhaber P. Bacterial overgrowth in ileal reservoirs (Koch pouch): Extended functional studies.  Hepatogastroenterology . 1980;  27 310-316
  • 266 Teria A, Okada Y, Shichiri Y. Vitamin B12 deficiency in patients with urinary intestinal diversion.  Int J Urol . 1997;  4 21-25
  • 267 Christl S U, Scheppach W. Metabolic consequences of total colectomy.  Scand J Gastroenterol Suppl . 1997;  222 20-24
  • 268 Isaacs P E, Kim Y S. The contaminated small bowel syndrome.  Am J Med . 1979;  67 1049-1057
  • 269 Murphy M F, Sourial N A, Burman J F. Megaloblastic anaemia due to vitamin B12 deficiency caused by small intestinal bacterial overgrowth: Possible role of vitamin B12 analogues.  Br J Haematol . 1986;  62 7-12
  • 270 Riordan S M, McIver C J, Wakefield D. Small intestinal bacterial overgrowth in the symptomatic elderly.  Am J Gastroenterol . 1997;  92 47-51
  • 271 Swan R W. Stagnant loop syndrome resulting from small-bowel irradiation injury and intestinal by-pass.  Gynecol Oncol . 1974;  2 441-445
  • 272 Kinn A C, Lantz B. Vitamin B12 deficiency after irradiation for bladder carcinoma.  J Urol . 1984;  131 888-890
  • 273 Lantz B, Einhorn N. Intestinal damage and malabsorption after treatment for cervical carcinoma.  Acta Radiol Oncol . 1984;  23 33-36
  • 274 Yeoh E K, Lui D, Lee N Y. The mechanism of diarrhoea resulting from pelvic and abdominal radiotherapy; a prospective study using selenium-75 labelled conjugated bile acid and cobalt-58 labelled cyanocobalamin.  Br J Radiol . 1984;  57 1131-1136
  • 275 Ludgate S M, Merrick M V. The pathogenesis of post-irradiation chronic diarrhoea: Measurement of SeHCAT and B12 absorption for differential diagnosis determines treatment.  Clin Radiol . 1985;  36 275-278
  • 276 Festen H P. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract.  Scand J Gastroenterol Suppl . 1991;  188 1-7
  • 277 Snijders-Keilholz A, Griffioen G, Davelaar J, Trimbos J B, Leer J W. Vitamin B12 malabsorption after irradiation for gynaecological tumours.  Anticancer Res . 1993;  13 1877-1881
  • 278 Yeoh E, Horowitz M, Russo A. Effect of pelvic irradiation on gastrointestinal function: A prospective longitudinal study.  Am J Med . 1993;  95 397-406
  • 279 Gee M I, Grace M G, Wensel R H, Sherbaniuk R W, Thomson A B. Nutritional status of gastroenterology outpatients: Comparison of inflammatory bowel disease with functional disorders.  J Am Diet Assoc . 1985;  85 1591-1599
  • 280 Lashner B A, Heidenreich P A, Su G L, Kane S V, Hanauer S B. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.  Gastroenterology . 1989;  97 255-259
  • 281 Levin B. Ulcerative colitis and colon cancer: Biology and surveillance.  J Cell Biochem Suppl . 1992;  47-50
  • 282 Lashner B A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.  J Cancer Res Clin Oncol . 1993;  119 549-554
  • 283 Glynn S A, Albanes D, Pietinen P. Colorectal cancer and folate status: A nested case-control study among male smokers.  Cancer Epidemiol Biomarkers Prev . 1996;  5 487-494
  • 284 Biasco G, Zannoni U, Paganelli G M. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis.  Cancer Epidemiol Biomarkers Prev . 1997;  6 469-471
  • 285 Itzkowitz S H. Inflammatory bowel disease and cancer.  Gastroenterol Clin North Am . 1997;  26 129-139
  • 286 Ma J, Stampfer M J, Giovannucci E. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.  Cancer Res . 1997;  57 1098-1102
  • 287 Mouzas I A, Papavassiliou E, Koutroubakis I. Chemoprevention of colorectal cancer in inflammatory bowel disease?.  A potential role for folate. Ital J Gastroenterol Hepatol . 1998;  30 421-425
  • 288 Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency.  Scand J Clin Lab Invest Suppl . 1994;  219 61-76
  • 289 Savage D G, Lindenbaum J, Stabler S P, Allen R H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.  Am J Med . 1994;  96 239-246
  • 290 Stabler S P, Lindenbaum J, Allen R H. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency.  J Nutr . 1996;  126 1266S-1272S
  • 291 Rasmussen K, Vyberg B, Pedersen K O, Brochner-Mortensen J. Methylmalonic acid in renal insufficiency: Evidence of accumulation and implications for diagnosis of cobalamin deficiency.  Clin Chem . 1990;  36 1523-1524
  • 292 Landgren F, Israelsson B, Lindgren A. Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid.  J Intern Med . 1995;  237 381-388
  • 293 Egerton W, Silberberg J, Crooks R. Serial measures of plasma homocyst(e)ine after acute myocardial infarction.  Am J Cardiol . 1996;  77 759-761
  • 294 Lindgren A, Brattstrom L, Norrving B. Plasma homocysteine in the acute and convalescent phases after stroke.  Stroke . 1995;  26 795-800
  • 295 Sheehan N J, Stanton-King K. Polyautoimmunity in a young woman.  Br J Rheumatol . 1993;  32 254-256
    >